studying the screening of PKU in france with the new tandemMS
Nationwide cohort study of the new pku screening for patient beetwen 180 and 360 µmol/L.
Study Type
OBSERVATIONAL
Enrollment
360
CHRU NANCY hopital enfant
Nancy, France
developping an PKU: id phenylanine over 360µmol/L
based on level of phenylalanine during the year of follow up
Time frame: 1 year
screening value
determining the bets screening value
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.